Localization and Quantification of Proliferating Cells During Rat Fracture Repair: Detection of Proliferating Cell Nuclear Antigen by Immunohistochemistry

Bilateral femurs of 12‐week‐old female Sprague‐Dawley rats were fractured, and the fractured femurs were harvested 36 h, 3, 7, 10, and 14 days after the fracture. Localization of cell proliferation in the fracture calluses was investigated using immunohistochemistry with antiproliferating cell nuclear antigen (PCNA) monoclonal antibodies. Thirty‐six hours after the fracture, many PCNA‐positive cells were observed in the whole callus. The change was not limited to mesenchymal cells at the fracture site where the inflammatory reaction had occurred, but extended in the periosteum along almost the entire femoral diaphysis where intramembranous ossification was initiated. On day 3, periosteal cells or premature osteoblasts in the newly formed trabecular bone during intramembranous ossification still displayed intense staining. On day 7, many premature chondrocytes and proliferating chondrocytes were PCNA positive. Endochondral ossification appeared on days 10 and 14, and the premature osteoblasts and endothelial cells in the endochondral ossification front were stained with anti‐PCNA antibodies. Quantification of PCNA‐positive cells was carried out using an image analysis computer system, obtaining a PCNA score for each cellular event. The highest score was observed in the periosteum early after the fracture near the fracture site. Immunohistochemistry using anti‐PCNA antibodies showed that the distribution of proliferating cells and the degree of cell proliferation varied according to the time lag after the fracture, suggesting the existence of local regulatory factors such as growth factors, and that significant cell proliferation was observed at the beginning of each cellular event.

[1]  T. Einhorn,et al.  Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  M. Bolander,et al.  Transforming growth factor-beta in the regulation of fracture repair. , 1990, The Orthopedic clinics of North America.

[3]  Kathleen,et al.  An Auxiliary Protein for DNA Polymerase-6 from Fetal Calf Thymus * , 2022 .

[4]  C. Tan,et al.  An auxiliary protein for DNA polymerase-delta from fetal calf thymus. , 1986, The Journal of biological chemistry.

[5]  M. Bolander,et al.  Genetic expression of extracellular matrix proteins correlates with histologic changes during fracture repair , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Rochelle L. Garcia,et al.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. , 1989, The American journal of pathology.

[7]  R. Bravo,et al.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ , 1987, Nature.

[8]  S. Fey,et al.  Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. , 1981, Experimental cell research.

[9]  D. Lane,et al.  Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. , 1990, Journal of cell science.

[10]  S. Fey,et al.  Identification of a nuclear polypeptide ("cyclin") whose relative proportion is sensitive to changes in the rate of cell proliferation and to transformation. , 1982, Progress in clinical and biological research.

[11]  J. Wray,et al.  Cellular proliferation in the formation of fracture callus in the rat tibia. , 1973, Clinical orthopaedics and related research.

[12]  J. Celis,et al.  Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Cronkite,et al.  CELLULAR RESPONSE TO FRACTURE STUDIED WITH TRITIATED THYMIDINE , 1961 .

[14]  M. Mathews,et al.  Regulation of proliferating cell nuclear antigen during the cell cycle. , 1989, The Journal of biological chemistry.

[15]  D. Lane,et al.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. , 1991, Journal of clinical pathology.

[16]  Y. Usson,et al.  Intranuclear co-location of newly replicated DNA and PCNA by simultaneous immunofluorescent labelling and confocal microscopy in MCF-7 cells. , 1992, Journal of cell science.

[17]  D. Lane,et al.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms , 1990, The Journal of pathology.

[18]  B. Franza,et al.  Identity of the proliferating cell nuclear antigen and cyclin , 1984, Nature.

[19]  E. Tan,et al.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. , 1987, Archives of pathology & laboratory medicine.

[20]  J. Celis,et al.  A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells , 1980, The Journal of cell biology.

[21]  B. Stillman,et al.  Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein , 1987, Nature.

[22]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  Y. Oda,et al.  The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma , 1993, Cancer.

[24]  G. Brugal,et al.  Image analysis of in situ cell cycle related changes of PCNA and Ki‐67 proliferating antigen expression , 1994 .

[25]  K. Aozasa,et al.  Prognostic significance of argyrophilic nucleolar organizer staining in soft‐tissue sarcomas , 1991, International journal of cancer.

[26]  R. Warnke,et al.  Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. , 1991, The American journal of pathology.

[27]  E. Tan,et al.  Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. , 1987, Experimental cell research.